May in Review: 12 Top Technology Press Releases

A roundup of the most newsworthy tech announcements from PR Newswire, including national security and nuclear projects, XREAL's new see-through optical device and PepsiCo's digital transformation plans. With thousands of press releases published each month, it can be difficult to keep up with everything on PR Newswire. To help tech journalists and consumers stay on […]

Lucinity Appoints Payoneer CCO and Goldman Sachs MD as Strategic Advisors

Lucinity Appoints Payoneer CCO and Goldman Sachs MD as Strategic Advisors GlobeNewswire June 06, 2025 REYKJAVIK, Iceland, June 06, 2025 (GLOBE NEWSWIRE) — Lucinity has expanded its Advisory Council with the appointment of industry leaders Micheal Sheehy, Chief Compliance Officer at Payoneer, and Konstantinos Rizakos, Managing Director of Compliance Engineering at Goldman Sachs. Both bring

Deep Isolation Joins International WISARD Initiative to Build Integrated Waste Solutions for a Sustainable Nuclear Future

Deep Isolation Joins International WISARD Initiative to Build Integrated Waste Solutions for a Sustainable Nuclear Future GlobeNewswire June 06, 2025 BERKELEY, Calif., June 06, 2025 (GLOBE NEWSWIRE) — Deep Isolation, a leading innovator in nuclear waste disposal technology, today announced its participation in the newly launched WISARD (Waste Integration for Small and Advanced Reactor Designs),

Rectify Pharma Presents Translational Data Demonstrating Improvements in Kidney Function and Reductions in Vascular Calcification at ERA 2025

Potent, selective ABCC6-targeting positive functional modulator (PFM) improved multiple markers of renal function in animal models of chronic kidney disease (CKD) PFM improved inorganic pyrophosphate (PPi) efflux via on-target engagement of the ABCC6 membrane transporter and reduced vascular calcification in animal models of CKD BOSTON, June 06, 2025 (GLOBE NEWSWIRE) — Rectify Pharmaceuticals, Inc., (“Rectify”)

Ferrellgas Partners, L.P. Reports Third Quarter Fiscal Year 2025 Results

(PinkSheets:FGPR),(Pinksheets:FGPR), LIBERTY, Mo., June 06, 2025 (GLOBE NEWSWIRE) — Ferrellgas Partners, L.P. (OTC: FGPR) (“Ferrellgas” or the “Company”) today reported financial results for its 2025 third fiscal quarter ended April 30, 2025. Tamria Zertuche, President and Chief Executive Officer, commented, “We are very pleased to have delivered strong third quarter sales growth of 9%, which

AxonDAO Launches CureRING: The Health Wearable That Pays Users for Their Data

Cheyenne, Wyoming, USA, June 06, 2025 (GLOBE NEWSWIRE) — AxonDAO, a pioneer in decentralized science and health data sovereignty, today unveiled CureRING, an innovative wearable device that enables users to own, protect, and earn compensation for their health data. Pre-orders are now shipping, and the device is available for public purchase. CureRING introduces a new

Quarterhill Appoints David Charron as Chief Financial Officer

Experienced public technology companyCFO brings deep capital markets and M&A expertise to support Quarterhill's next growth phase Quarterhill Inc. (“Quarterhill” or the “Company”) (TSX: QTRH) (OTCQX: QTRHF), today announced the appointment of David Charron as Chief Financial Officer (“CFO”), effective June 17, 2025. Mr. Charron brings more than 15 years of public company CFO experience

Thermoplastic Elastomers Market worth $38.94 billion by 2030- Exclusive Report by MarketsandMarkets™

The report “Thermoplastic Elastomers Marketby Type (SBC, TPU, TPO, TPV, COPE, PEBA), End-use Industry (Automotive, Building & Construction, Footwear, Wire & Cable, Medical, Engineering), Region – Global Forecast to 2030”, is expected to reach USD 38.94 billion by 2030 from USD 30.83 billion in 2025, at a CAGR of 4.8%. https://mma.prnewswire.com/media/1868219/MarketsandMarkets_Logo.jpg The thermoplastic elastomers market

Rectify Pharma Presents Translational Data Demonstrating Improvements in Kidney Function and Reductions in Vascular Calcification at ERA 2025

Rectify Pharma Presents Translational Data Demonstrating Improvements in Kidney Function and Reductions in Vascular Calcification at ERA 2025 GlobeNewswire June 06, 2025 Potent, selective ABCC6-targeting positive functional modulator (PFM) improved multiple markers of renal function in animal models of chronic kidney disease (CKD) PFM improved inorganic pyrophosphate (PPi) efflux via on-target engagement of the ABCC6

AxonDAO Launches CureRING: The Health Wearable That Pays Users for Their Data

AxonDAO Launches CureRING: The Health Wearable That Pays Users for Their Data GlobeNewswire June 06, 2025 Cheyenne, Wyoming, USA, June 06, 2025 (GLOBE NEWSWIRE) — AxonDAO, a pioneer in decentralized science and health data sovereignty, today unveiled CureRING, an innovative wearable device that enables users to own, protect, and earn compensation for their health data.

Scroll to Top